Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in severe depression
NCT03380442Phase 2Unknown
- Sponsor
- University of Helsinki
- Start
- Sep 2018
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of psilocybin in major depressive disorder (MDD), sponsored by University of Helsinki. Status: unknown.
02
Drugs
psilocybin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03380442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380442.